Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vivian Naidoo"'
Publikováno v:
Journal of Primary Care & Community Health, Vol 15 (2024)
The South African government is moving toward universal health coverage (UHC) with the passing of the National Health Insurance (NHI) Bill. Access to quality primary healthcare (PHC) is the cornerstone of UHC principles. The South African governmenta
Externí odkaz:
https://doaj.org/article/91c76aaaddf54e2b9f16909980a1d524
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 16, Iss 1, Pp 1-18 (2023)
Abstract Background Universal health coverage has gained significant momentum internationally as the policy solution to address healthcare system deficiencies and promote equitable distribution of quality healthcare. The South African government has
Externí odkaz:
https://doaj.org/article/8a46d080ba844971a5da33e7893d7565
Autor:
Vivian Naidoo BPharm, MPharm, Rajatheran Moodley BSc, BPharm, MPhil, PhD, Varsha Bangalee BPharm, MPharm, PhD, Fatima Suleman BPharm, MPharm, PhD
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 60 (2023)
The implementation of universal health coverage (UHC) in South Africa has focused on promoting equitable health care services to all citizens. In this regard, pharmacists are expected to expand their professional capabilities to promote primary healt
Externí odkaz:
https://doaj.org/article/0a220e5699784056929b9353fe8c11e0
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257348 (2021)
BackgroundThe implementation of Universal Health Coverage in SA has sought to focus on promoting affordable health care services that are accessible to all citizens. In this regard, pharmacists are expected to play a pivotal function in the revitaliz
Externí odkaz:
https://doaj.org/article/0d63861d06254b41a082b0904efaa5a6
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/93e26743b3b1432bb8b0614fef7bfadb
Autor:
Sphamandla Ntshangase, Thavendran Govender, Sipho Mdanda, Vivian Naidoo, Tricia Naicker, Hendrik G. Kruger, Sooraj Baijnath, Panjasaram Naidoo
Publikováno v:
Journal of Psychiatric Research. 112:7-11
Ketamine is approved by the FDA to be used as an anesthetic however, recent reports have exhibited its success in the treatment of major depressive disorder (MDD). Studies have suggested that a sub-anesthetic dose produces rapid antidepressant activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc8cdb6372c2407077fb34570897a6a
https://doi.org/10.1016/j.jpsychires.2019.02.003
https://doi.org/10.1016/j.jpsychires.2019.02.003